In May 2020, Australian researchers published a little-known study in the journal Antiviral Research that presents ivermectin, an FDA-approved drug for humans, as a “broad spectrum antiviral of interest.” RNA viruses such as human immunodeficiency virus (HIV)-1, influenza and dengue fever, the paper suggests, could be mitigated through the use of ivermectin, which blocks viral components from taking hold inside … Continue reading STUDY: Ivermectin is a “broad spectrum antiviral of interest” for humans
Dr. Eddy Bettermann MD 